Lab closures 2019

We offer seven-business-day turnaround for all tests, and a three-business-day rush turnaround option for most tests, except microbiology testing. Our lab is only closed on the following statutory holidays.

Good Friday
Friday, April 19
Easter Monday
Monday, April 22
Victoria Day
Monday, May 20
Canada Day
Monday July 1
B.C. Day
Monday August 5
Labour Day
Monday September 2
Thanksgiving Day
Monday October 14
Remembrance Day
Monday November 11
Christmas Day
Wednesday December 25
Boxing Day
Thursday, December 26
  • Turnaround times explained

    Standard turnaround is 7 business days

    Rush turnaround is 3 business days, except for microbiology, which can’t be rushed

    Even if microbiology is required, a rush option is still available for all other tests

    Microbiology tests start on the first Monday, Wednesday or Friday after receiving your samples

    Samples have to arrive before 3pm PST on a business day

    Once we received your samples, we’ll confirm by email when you can expect your results

  • How to submit a sample

    New clients
    Please contact us. We need to register you as a client before you can submit any samples.

    Registered clients

    1 – Download the relevant Chain of Custody (COC) Form

    COC – Flower and oil

    COC – Edibles and topicals

    COC – Concentrates

    2 – Email your completed form to for review.

    3 – Once your COC has been approved, send it together with your samples to:

    Anandia, Testing Division
    125-887 Great Northern Way
    Vancouver, BC, V5T 4T5

    4 – You will receive an email confirmation that your package has been received, which will include the date your results can be expected.

  • Required sample amounts

    Package testing: 60 g (flower) or 60 mL (oil)

    Potency: 10g (flower) or 5mL (oil)

    Cannabinoid profiling: 10g (flower) or 5mL (oil)

    Heavy metal or total metal: 3g (flower) or 1mL (oil)

    Aflatoxin analysis: 3g (flower) or 1mL (oil)

    Ochratoxin analysis: 3g (flower) or 1mL (oil)

    Loss on drying: 3g (flower)

    Terpene profiling: 10g (flower) or 1mL (oil)

    Residual solvents: 1mL (oil)

    Pesticide analysis (96 Analytes): 3g (flower) or 2mL (oil)

    Microbiology (all required tests): 40g (flower) or 40mL (oil)

    TAMC: 10g (flower) or 10mL (oil)

    TYMC: 10g (flower) or 10mL (oil)

    BTGN: 1g (flower) or 1mL (oil)

    E. coli: 1g (flower) or 1mL (oil)

    Salmonella: 25g (flower) or 25mL (oil)

    S. aureus: 1g (flower) or 1mL (oil)

    P. aeruginosa: 1g (flower) or 1mL (oil)

Canada’s Potential Cannabis Demand and Supply Issues Heating up Heading Into the Summer

Major developments taking place in the legal cannabis industry in North America, particularly CanadaCanada is just about on the cusp of legalizing recreational marijuana through Bill C-45, which is best known as the Cannabis Act that is highly anticipated to be signed into law very soon. The long enduring process and expected legalization of recreational cannabis is a long time coming for marijuana industry as a whole. The long process for the Bill C-45 first made its way to Canada’s Senate just about 14 months ago, and was only voted on after numerous debates, speeches, and amendments just recently. Industry experts are not certain what the demand and supply picture will look like in Canada because it often takes Health Canada a long time to issue cultivation licenses and sales permits. But either way, as the long waited day approaches, active companies in the industry are making moves to ready that include: Choom™ Holdings Inc. (CSE:CHOO) (OTC:CHOOF), Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF), Canopy Growth Corp. (TSX:WEED) (NYSE : CGC ), Aphria Inc. (TSX:APH) (OTC:APHQF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF).

Choom™ Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) BREAKING NEWS: Choom™, an emerging fully-integrated cannabis company, is pleased to announce it has closed its previously announced non-brokered private placement (June 13, 2018). The Company issued 14,225,352 shares for total gross proceeds of $10.1 million. Aurora Cannabis is the cornerstone investor in the placement with a lead order of $7 million. All securities issued are subject to a four month hold period.

“The financing provides us with the funds to accelerate the execution of our unique retail strategy moving forward,” states Chris Bogart, CEO and President of Choom. “We are now well positioned to expand our production and retail footprint, as well as, pursue further opportunities across Canada.”

None of the securities issued in connection with the placement will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there by any sale of the securities in any state where such offer, solicitation, or sale would be unlawful. Read this and more news for Choom™ at:

Additional industry related developments from around the markets:

Aurora Cannabis Inc. (TSX:ACB.TO) (OTCQX:ACBFF) and Anandia Laboratories Inc. have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately held Anandia in an all-share transaction valued at approximately $115-million on a fully diluted basis.  Led by chief executive officer and co-founder Dr. Jonathan Page, PhD, one of the industry’s most widely recognized cannabis experts, Anandia is considered the industry leader in science, genetics and independent cannabis product testing. Dr. Page was the first scientist to sequence the cannabis genome and provide deep insights into the biosynthesis of cannabinoids and the interplay between cannabinoids and terpenes.

Canopy Growth Corp. (TSX: WEED.TO) (NYSE : CGC ) has priced its previously announced offering of convertible senior notes due 2023. The company will issue $500-million aggregate principal amount of the notes. Canopy Growth has granted the initial purchasers of the notes an option to purchase up to an additional $100-million aggregate principal amount of notes. The offering was upsized from the previously announced $400-million aggregate principal amount. Cowen and Company LLC and BMO Nesbitt Burns Inc. are acting as joint book-running managers, and Eight Capital and Bryan, Garnier & Co. are acting as co-managers for this offering. Canopy Growth has been advised by Greenstar Canada Investment LP, an affiliate of Constellation Brands Inc., that it intends to participate in the offering.

Aphria Inc. (TSX: APH.TO) (OTCQB:APHQF) has appointed Joel Toguri as vice-president of sales, effective on June 18, 2018. Mr. Toguri joins the company from Southern Glazer’s of Canada, where he was vice-president of sales and operations since 2013. “We’re thrilled to bring Joel’s incredible talent and considerable experience to Aphria,” said Jakob Ripshtein, chief commercial officer at Aphria. “Over many years, Joel has developed a proven track record of driving sales, generating growth and delivering results. His experience in building Southern Glazer’s in Canada and his deep familiarity with our exclusive sales distribution partner will help to ensure Aphria’s brands and products are successfully represented by cannabis retailers throughout the country.”

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD.TO) (OTCQX: TGODF) has entered into a strategic partnership with Epican Medicinals Ltd. This partnership will add an additional 14,000 kilograms, taking Green Organic’s total organic financed capacity to 130,000 kg. Epican is a vertically integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licences. This strategic partnership introduces Green Organic’s premier organic cannabis brand to the international medical market. “This represents the first of many strategic partnerships TGOD intends to execute in the coming months,” said Robert Anderson, chief executive officer. “Our value-added approach taken in this investment will set an international M&A framework for capital investment, transfer of knowledge and sector expertise. We will continue to evaluate international opportunities that will assist us in executing our business plan to become the world’s largest organic cannabis brand,” continued Mr. Anderson.

DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed MNU has been compensated forty five hundred dollars for news coverage of the current press release issued above by Choom™ Holdings Inc. by a non affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Jane Doe, Public Relations
123 – 456 – 7890


Emerald Badges

The Emerald Test™ is an Inter-Laboratory Comparison and Proficiency Test (ILC/PT) program for cannabis testing labs. Proficiency test samples are manufactured by an ISO 17043 accredited PT provider. Results are submitted through an electronic data portal and data analysis is provided by the sample manufacturer with software designed to meet the requirements of ISO 13528:2015.

Every path to success is tested

Please confirm your age and province.

The results are in

In , you must be at least years old to proceed.

This website uses cookies to enable essential features, please review our Cookie Policy for more information on how to manage and personalize your experience.